Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Zhongping Lily Mao"'
Autor:
Nishit B. Modi, Zhongping Lily Mao
Publikováno v:
Journal of Clinical Pharmacology
Parkinson disease is an age‐related disorder of the central nervous system principally due to loss of dopamine‐producing cells in the midbrain. Levodopa, in combination with carbidopa, is widely regarded as an effective treatment for the symptoms
Publikováno v:
Drug Metabolism Letters. 5:114-125
Vernakalant hydrochloride is a novel antiarrhythmic drug for the rapid conversion of atrial fibrillation to sinus rhythm and prevention of relapse. In this open-label, parallel design study, 8 healthy men received single 240-mg doses of [ 14 C]vernak
Autor:
James Keirns, Yuying Gao, Jeffrey J. Wheeler, Helen Kastrissios, Zhongping Lily Mao, Robert Townsend
Publikováno v:
Journal of clinical pharmacology. 52(7)
Vernakalant hydrochloride is a novel, predominantly atrial-selective antiarrhythmic drug that effectively and rapidly terminates atrial fibrillation (AF). Plasma vernakalant concentration data from 5 phase 2 and 3 clinical trials of vernakalant in pa
Publikováno v:
Clinical therapeutics. 31(7)
Background: Conivaptan is a nonpeptide vasopressin V 1A /V 2 -receptor antagonist that produces a controlled increase in serum sodium concentration in hospitalized patients with euvolemic or hyper-volemic hyponatremia. Objective: This study evaluated